What Chronic Inflammation Actually Does to the Body as You Age

Chronic inflammation is a normal part of getting older, but when it runs unchecked for years, it becomes one of the strongest drivers of how fast the body actually ages, separate from the number on a birth certificate. Its effects are cumulative, building quietly across decades rather than appearing all at once. This article breaks down how chronic inflammation develops, how its effects compound over time, and what the science says about measuring and managing it. 

Want the fuller picture first? Read Chronic Inflammation & Inflammaging: The Hidden Driver of How You Age for a deeper look at the mechanism before diving into the decade-by-decade effects below.

The baseline: acute vs. chronic inflammation

Inflammation is simply the body's natural defense mechanism against injury, infection, and damage. The acute version is short-lived and resolves once a threat is handled; chronic inflammation is what happens when that response fails to switch off and instead persists at a low, steady level for months or years, quietly affecting tissue and organs even when there is no active threat to fight. 

Inflammaging: where chronic inflammation meets biological aging 

Inflammaging describes the specific intersection where chronic, low-grade inflammation and the aging process meet, and it is now recognized as one of the hallmarks of aging in its own right. As we get older, chronic inflammation gradually becomes a more prominent part of our biological landscape, driven by a combination of factors that accumulate over a lifetime: exposure to environmental toxins, chronic infections, cellular senescence, and the gradual weakening of the immune system.

Growing older also brings a decline in immune effectiveness, and that decline is intimately tied to chronic inflammation, which plays a pivotal role in eroding the body's defenses over time. As a result, chronic inflammation is a substantial risk factor for both illness and mortality in older adults. Chronic inflammatory diseases are collectively among the leading causes of death worldwide, underscoring why researchers increasingly treat inflammation as a target for prevention rather than something to address only after a diagnosis. 

These effects are not confined to older adults, either. In younger people, chronic inflammation can take root and advance silently for years before symptoms appear, which is exactly what makes it easy to miss until the diseases it drives, cardiovascular disease, metabolic syndrome, neurodegenerative conditions, autoimmune disorders, and cancer among them, have already begun to take hold.

How the effects of chronic inflammation show up over time 

The effects of chronic inflammation are cumulative, not sudden, so they tend to surface differently depending on how long the underlying process has been active and which systems have absorbed the most wear.

In your 40s: inflammatory markers typically begin a slow, steady climb, even in people who feel healthy. Insulin sensitivity starts to dip, metabolism slows, and minor joint stiffness or slower recovery after exercise can appear years before any diagnosis. Skin may start losing elasticity a little faster than expected, and gut lining resilience can begin to waver.

In your 50s: the slow climb from the previous decade tends to accelerate, particularly around major hormonal shifts. In women, the menopause transition brings a measurable rise in IgG glycome markers of inflammation, reflected as a jump in biological age over a fairly short window. In men, a comparable, more gradual shift is linked to declining testosterone. 

"When estrogen levels are low or non-existent, we get this pro-inflammatory state."

— Dr. Louise Newson, GP and Menopause Specialist; Founder, Newson Health and the balance app 

In your 60s: decades of low-grade inflammation start to show up structurally. IgG glycosylation patterns linked to inflammation are associated with future cardiovascular events, consistent with arterial stiffening and elevated cardiovascular risk. More broadly, chronic inflammation in this period is also linked to brain fog and a higher long-term risk of cognitive decline. 

In your 80s: the cumulative wear becomes systemic. Immune defenses that have been chronically activated for decades grow markedly less responsive, cellular repair mechanisms falter, and the conditions chronic inflammation quietly built toward over the previous four decades, cardiovascular disease, metabolic syndrome, neurodegenerative decline, are the ones most likely to surface.

These are population-level patterns rather than a fixed schedule. Genetics, lifestyle, and how early the inflammatory process took hold can all shift this timeline earlier or later for any individual.

Why the body gets worse at turning inflammation off 

Acute inflammation is only useful if it ends. In younger, healthier physiology, once a threat is cleared, the body actively resolves the inflammatory response and returns tissue to baseline. This resolution process itself becomes less efficient with age, so each new stressor tends to leave behind a slightly higher inflammatory baseline than before. Over enough years, that failure to fully switch off is what turns isolated inflammatory episodes into the persistent, low-grade state associated with aging. 

Chronic inflammation and the breakdown of cellular repair 

Autophagy, the process cells use to clear out damaged proteins and worn-out components, is one of the official hallmarks of aging in its own right, and its efficiency naturally declines with age. Chronic inflammation accelerates that decline, and the resulting buildup of cellular debris can itself trigger further immune activation. The result is a cycle in which chronic inflammation slows repair, and slower repair generates more of the debris that keeps inflammation elevated. 

Chronic inflammation as an early, responsive biomarker 

While chronic inflammation is influenced by genetics, epigenetics, and environment, lifestyle remains one lever largely within personal control. Diet, exercise, sleep, and stress management all shape the internal environment that either promotes or mitigates chronic inflammation, and elevated chronic inflammation can flag rising health risk years before any disease is diagnosed.

Because chronic inflammation is itself a hallmark of aging, elevated levels driven by lifestyle point to a higher biological age and a faster aging process, distinct from chronological age.

"In many inflammatory diseases, IgG glycans change up to a decade before people are diagnosed with the disease."

— Prof. Gordan Lauc, Co-Founder and Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

Managing chronic inflammation for a healthier tomorrow

We have the power to mitigate some of the harmful effects of chronic inflammation, especially those caused by our lifestyle choices. Embracing healthier habits can lower chronic inflammation and shift its long-term trajectory toward a healthier aging process. Nonetheless, there are limits to what we can reverse independently.

As mentioned, chronic inflammation is shaped by factors such as genetics, epigenetics, and environmental elements, which often lie beyond our immediate control. Consider, for instance, hormonal imbalances, an influential contributor to chronic inflammation. During menopause, women frequently experience elevated levels of inflammation, resulting in a sudden increase in their biological age. Here, hormone replacement therapy has proven highly beneficial in addressing this issue, though its effect on biological age varies depending on formulation, dosage, and individual response. In other cases, individuals may carry genetic predispositions for conditions like cardiovascular disease. These individuals require a personalized approach and medical therapies tailored to their specific needs.

Nevertheless, we have the capacity to regulate our chronic inflammation levels, either independently or with the guidance of healthcare professionals, facilitating a healthier aging process.

Decoding chronic inflammation with the help of glycans

Because chronic inflammation drives a gap between biological age and chronological age, measuring it accurately matters. Traditional markers like C-Reactive Protein (CRP) and inflammatory cytokines offer valuable insights, but they have shorter half-lives that make them better suited for acute inflammation assessments. The story changes when we turn our attention to Immunoglobulin G (IgG) antibodies.

IgG antibodies play a pivotal role in our immune system, acting as functional effectors that modulate various immune response pathways by binding to specific receptors on the surface of immune cells.

Glycans, complex sugar structures, become integral components of IgG antibodies during their production, and unlike genes, they don't follow a fixed genetic template.

"Glycan biosynthesis is not template-driven, like nucleic acid and protein synthesis."

— Dr. Olga Zaytseva, PhD, Geneticist and Researcher, Genos Glycoscience Research Laboratory, Zagreb

Instead, glycan composition results from a complex interplay of genetics, epigenetics, and environmental factors. IgG can carry around 30 different glycan structures, each uniquely influencing its functionality. Glycans that drive IgG to activate immune pathways are considered pro-inflammatory, while those that don't are considered anti-inflammatory. Collectively, these diverse IgG glycans form the IgG glycome. What sets IgG antibodies apart from other markers is their longevity in the bloodstream. With a half-life of approximately three weeks, IgG allows a unique glimpse into the dynamics of chronic inflammation.

As aging progresses, the composition of the IgG N-glycome undergoes a significant shift, transitioning IgG functionality from an anti-inflammatory to a pro-inflammatory state. This unique interplay makes the IgG glycome an exceptional biomarker for biological aging.

Seeing the effects of chronic inflammation before disease does

Chronic inflammation builds up quietly, which is exactly what makes it dangerous. The IgG glycome offers a way to see this process in motion, tracking whether the immune system is trending toward a pro-inflammatory or anti-inflammatory state, and whether lifestyle changes are actually working.

GlycanAge measures this directly through an at-home biological age test built around IgG glycosylation. Retesting is typically recommended six to twelve months after lifestyle changes, or three to four months after starting a pharmaceutical or hormonal intervention, since the two work on different timelines.

If you want to see where you currently stand and monitor how your choices are shifting your biological age over time, explore GlycanAge for personal use and get your first result within weeks.

External sources

• https://pmc.ncbi.nlm.nih.gov/articles/PMC7147972/ — Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832. 

• https://pubmed.ncbi.nlm.nih.gov/36599349/ — López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. 

• https://pubmed.ncbi.nlm.nih.gov/10911963/ — Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254. 

• https://pubmed.ncbi.nlm.nih.gov/24325898/ — Krištić J, Vučković F, Menni C, et al. Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2014;69(7):779-789. 

• https://pubmed.ncbi.nlm.nih.gov/30107893/ — Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65-79. 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC4202688/ — Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.